Ravimid risankizumab, vedolizumab ja tesepelumab
Contracts total
592 785 €
Bids
1
Type
Supplies
Published
13.02.2024
Tender description
Ravimite ostmine vastavalt RHAD lisas I Tehniline kirjeldus-pakkumuse vorm kirjeldatule.
Awarded contracts
19.04.2024| Lot | Tenderer | Amount | Bids | Awarded |
|---|---|---|---|---|
| Risankizumab | MAGNUM MEDICAL OÜ | 231 385 € | 1 | 19.04.2024 |
| Vedolizumab | TAMRO EESTI OÜ | 260 621 € | 1 | 15.04.2024 |
| Tesepelumab | MAGNUM MEDICAL OÜ | 100 779 € | 1 | 19.04.2024 |
Tender lots
3| Lot | Estimated value | Deadline |
|---|---|---|
| Risankizumab | 255 000 € | 15.03.2024 |
| Vedolizumab | 265 000 € | 15.03.2024 |
| Tesepelumab | 110 000 € | 15.03.2024 |
Similar open tenders
- Parenteraalsed toitelahusedOpen for bidsDeadline 20.10.2026 2 daysEstimated value 400 000 €Published 18.09.2026
- KlesrovimabOpen for bidsDeadline 20.10.2026 2 daysEstimated value 190 000 €Published 05.10.2026
- Puhasruumide desinfektsiooni- ja puhastusvahendidOpen for bidsDeadline 21.10.2026 3 daysPublished 17.09.2026
- Urogenitaalsüsteemi ravimid ja hormoonravimidOpen for bidsDeadline 23.10.2026 4 daysPublished 18.09.2026
- Ravim B01AB05 EnoksapariinOpen for bidsDeadline 27.10.2026 9 daysPublished 21.09.2026
- Kemoteraapias kasutatavad ravimidOpen for bidsDeadline 27.10.2026 9 daysPublished 22.09.2026
Source: Public Procurement Register open data. Amounts exclude VAT. The notice published in the Public Procurement Register is binding.